NIS-encoding non-replicating ADV, which was studied in thexenografts of various human cancers, including cervical cancer, breast cancer,and prostate cancer (PCa), as well as in immunodeficient mouse models, was thefirst NIS-expressing virus obtained [67]. Here, SLC5A5 is linked to prostate cancer.